Literature DB >> 17333839

Primary and acquired drug resistance in childhood tuberculosis.

S Khalilzadeh1, M R Boloorsaz, A Safavi, P Farnia, A A Velayati.   

Abstract

This study determined the resistance pattern of Mycobacterium tuberculosis to 4 first-line anti-tuberculosis drugs in children with pulmonary tuberculosis at the Iranian National Research Institute of Tuberculosis and Lung Diseases from 1999 to 2004. There were 350 children with positive cultures over the study period: 7 (2%) were resistant to at least one of the 4 anti-tuberculosis drugs. Primary resistance was detected in 4 cases and secondary resistance in 3 cases. Most cases (6) were among Afghan refugees. Resistance to rifampicin both in primary and secondary resistances was high, showing that children in the Islamic Republic of Iran face the threat of drug-resistant tuberculosis transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17333839

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  5 in total

1.  Evaluation of gene mutations involved in drug resistance in mycobacterium tuberculosis strains derived from tuberculosis patients in mazandaran, iran, 2013.

Authors:  Farhang Babamahmoodi; Mohammad Reza Mahdavi; Hossein Jalali; Bita Talebi; Payam Roshan; Mehrad Mahdavi
Journal:  Int J Mol Cell Med       Date:  2014

Review 2.  Multidrug resistance: an emerging crisis.

Authors:  Jyoti Tanwar; Shrayanee Das; Zeeshan Fatima; Saif Hameed
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-07-16

3.  Rapid Detection of Isoniazid Resistance in Mycobacterium tuberculosis by a Single Multiplex Allele-specific Polymerase Chain Reaction Assay.

Authors:  Kimia Taghavi; Parissa Farnia; Mohammad Varahram; Fatemeh Maryam Sheikhoslami; Mojtaba Ahmadi; Mehdi Kazempoor; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

Review 4.  Epidemiology and disease burden of tuberculosis in children: a global perspective.

Authors:  James A Seddon; Delane Shingadia
Journal:  Infect Drug Resist       Date:  2014-06-18       Impact factor: 4.003

Review 5.  Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.

Authors:  Sheetal Sharma; Panchali Barman; Shubhi Joshi; Simran Preet; Avneet Saini
Journal:  Colloids Surf B Biointerfaces       Date:  2021-12-20       Impact factor: 5.268

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.